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ABSTRACT
Objectives: To study the trends of drug utilization pattern in neonatal intensive care unit (NICU) at rural tertiary care hospital using the World Health 
Organization core indicators.
Methods: The study was cross-sectional, observational study in NICU of Government Medical College, Ambajogai, Maharashtra. Data were collected by 
scrutinizing the prescriptions written by pediatricians in NICU. The consent of parents of neonate was obtained for inclusion in the study. Parameters 
such as age, gender, birth weight, current illness, congenital anomalies, gestational age at birth, and drugs prescription analyzed.
Results: A total 220 prescription were scrutinized. Out of 220 neonates, 53.6% was males and 46.3% females. The total number of drugs prescribed 
was 808 and the average number of drugs per prescription was 3.6. The most frequently prescribed therapeutic class of drugs antimicrobial agents 
(60.64%) followed by vitamin K (26.7%) and aminophylline (9.4%). The maximum number (50%) of neonate born with birth weight <2.5. The 
maximum number (42%) of neonate was born at 34-36 weeks of gestation. Preterm low birth weight was the most common observed reason for 
admission to NICU. The drugs are prescribed by branded name outnumbered than generic name.
Conclusion: This study highlights the problem of overprescribing of antibiotics, inadequate labeling and a trend toward polypharmacy.
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INTRODUCTION
Rational use of drugs is defined by the World Health Organization 
(WHO) as “patients receives medicines appropriate to their clinical 
needs, in doses that meet their own individual requirements for an 
adequate period of time, at the lowest cost to them and their community. 
Drug utilization is an important component of pharmacoepidemiology 
and many research initiatives that examine the clinical and economical 
effectiveness of pharmacotherapy [1].
The study of prescribing pattern is a part of the medical audit and 
seeks to monitor, evaluate and if necessary, suggest modification 
in prescribing practices to make medical care rational and cost 
effective.
A neonatal intensive care unit (NICU) is a highly specialized unit that 
provides high quality skilled care to premature, low birth weight (LBW) 
or critically ill new born infants. Apart from facilities for continuous 
clinical and biochemical monitoring and the life support systems the 
neonatal intensive care management (NICU) involves the use of a wide 
range of medications with well-defined and specified therapeutic 
objectives.
Because of the immaturity of various organ functions such as kidney, 
liver, gastric motility, the neonates may show pharmacodynamic 
and pharmacokinetic variations making them more susceptible for 
adverse drug reactions, which are particularly more likely in high-
risk neonates such as premature, LBW or critically ill. Accordingly, 
caution is required while exposing such neonates to various 
medications [2]. They are more prone to development of adverse 
drug reactions as they have deficiency of metabolizing enzyme, 
immature excretion of the drug [3]. Besides, due to economic and 
ethical issues, children do not often participate in clinical trials, 
and specific knowledge about the effect of drugs in children is often 
inadequate [4].
In spite of many advances in neonatal care, currently, there are no 
standardized guidelines for the rational prescribing and individualizing the 
medication regimen in NICU. Moreover, the use of certain drugs in some 
NICUs may be an “off-label” means beyond the approved indication, and 
also their safety not being clearly established in high-risk neonates [5,6].
At present, very scanty data regarding overall pattern and extent of 
drug utilization in NICU, considering current scenario this study, are 
taken up with the purpose of generating some valid data and useful 
information for improving the quality of neonatal care.
METHODS
Approval from Institutional Ethics Committee was taken before the 
commencement of the study. The informed consent was obtained from 
parents/legal guardian all the study subjects.
The study was conducted in NICU of Government Medical College, 
Ambajogai, Beed, Maharashtra.
The study design
A cross-sectional study and study population include all neonate 
hospitalized in NICU in Government Medical College and Hospital.
The period of study April 2014-September 2014 with inclusion criteria,
Inclusion criteria
1. All neonates admitted to NICU, receiving one or more medications.
2. Willingness of parents/legal guardian to give informed consent for 
inclusion in the study.
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Exclusion criteria
1.	 Neonates	not	receiving	any	medications	other	than	 fluids/
electrolyte solution, parenteral nutrition, nutritional supplements, 
blood and blood products, oxygen, phototherapy, and vaccinations.
2. Neonates admitted to NICU for mother sake.
Data collection
•	 Data	were	 recorded	 in	 predesigned	 performa	 for	 the	 study;	
prescriptions	were	 evaluated	 for	 profile	 name,	 education	 and	
occupation of parents, diagnosis, birth weight, gestational age, 
congenital anomalies, and time of admission after birth.
•	 The	name,	formulation	drug,	route	of	drugs	administration,	generic	
and brand name, drugs, and from essential drug list.
Statistical analysis
Data were analyzed by Microsoft Office Excel 2007 and using descriptive 
statistics. Results were depicted in the form of percentages and graphs. 
A total of 220 prescriptions were scrutinized, over a period of 6 months 
from April 2014 to September 2014, on the basis of inclusion and 
exclusion criteria.
RESULTS
Data show that male neonates (53.6%), outnumbered female neonates 
(46.4%) (Fig. 1).
A total of drugs prescribed 808 and drugs were prescribed in the range 
of 1-6, that is minimum 1 to maximum 6 drugs per prescription. The 
average number of drugs per prescription was 3.6. The most frequently 
prescribed therapeutic class of drugs antimicrobial agents (60.64%) 
followed by vitamin K (26.7%) and aminophylline (9.4%) (Table 1). 
Most of the antimicrobials prescribed belonged to aminoglycosides 
group (gentamycin), followed by cephalosporin (cefotaxime) and 
carbapenem (meropenem) and all these drugs are given by parenteral 
route.
The drugs are prescribed by branded name outnumbered than a 
generic name. The maximum number (50%) of neonate was born with 
birth weight <2.5 (Table 2). The maximum number (42%) of neonate 
was born at 34-36 weeks of gestation (Fig. 2). The common neonatal 
conditions are preterm LBW (39%), neonatal sepsis (24%), birth 
asphyxia (11%), meningitis (6%), and others (20%).
Few number of neonates received bronchodialtors, antiepileptic drugs, 
and micronutrient compounds.
DISCUSSION
Drug utilization studies are the tools helps both prescribing physicians 
and the hospital administration regarding drug audit, and drug 
expenditure. Furthermore, helps in cost analysis which is an important 
parameter to decide whether it is a rational or not drug therapy. It is 
also helpful in framing hospital formulary and standard treatment 
guidelines as per the diagnosis. These studies not only guide for the 
rational use of drugs but are also helpful in making treatment cost-
effective and beneficial to patients and reduce the burden of poorly 
funded health system in developing countries like India [7-9].
In this study, the average number of drugs per encounter were 3.6 
consistent with study of Brijal et al. 2015 (4.4%) [2]. An average number 
of drugs per prescription should always be kept low as it can lead to 
increase in unnecessary cost of treatment, higher possibility of drug-
drug interaction, and also increase the risk of adverse drug reactions 
and antibiotic resistance.
Demographic profile shows male (54.3%) preponderance in 
neonates attending the NICU consistent with study of Brijal et al. 
2015 (60%) [2]. The gender discrimination in terms of access to 
health-care is apparent in the study. There is an immediate need to 
create awareness against gender discrimination which begins at the 
early age.
Table 1: Different therapeutic class of drug prescribed
Class of drugs prescribed n (%)
Antimicrobial agents 490 (60.64)






Table 2: Birth weight of neonate




> 4 kg 2
Fig. 1: Gender distribution of neonate
Fig. 2: Neonate born at gestational age
Findings were reported by majority (80.8) of the neonates were under
 7 days of age, indicating that most of neonatal diseases are 
common in early neonatal age. This is in accordance with study 
conducted by Junejo et al. [10,11] in which patients admitted in 
the early neonatal period were 83.4%. A neonate is particularly 
vulnerable to adverse influences such as asphyxia, infection, and 
complications of preterm birth. During early neonatal days (7) 
and requires special attention. Parenteral route is commonly seen 
in NICU and it plays crucial role in the management of sick neonates
 until they can tolerate enteral/oral feeding.
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The maximum number (85%) of neonate in our study was preterm 
showing trends toward preterm delivery. This finding is comparable to 
study of Neubert et al. [12] (54.6%). It is quite evident that significantly 
large (55.54%) number of neonates were LBW in our study. LBW 
infants remain vulnerable to malnutrition, recurrent infections, 
neurodevelopmental disabilities, and experience higher mortality [13].
LBW was the most common reason for admission to NICU, neonatal 
sepsis was the second most followed by birth asphyxia, meningitis, 
etc. Another study by Venkateswaramurthy et al. [14] of shows fever 
(34.6%), respiratory diseases (21.7%), gastrointestinal disorder 
(16.8%), and infection diseases (12.6%) were most common reasons 
for hospitalization. These differences can be attributed to the inclusion 
of different age group.
As shown in Table 1. most frequently used drugs in NICU were vitamin 
K and antibiotics among which amikacin, meropenem, cefotaxime, 
ampicillin, and gentamicin were commonly prescribed drugs.
Vitamin K deficiency bleeding is of particular concern in neonates as 
they are born with low levels of vitamin K. Current recommendations 
suggests single intramuscular administration of vitamin K is an 
effective, safe, and sustainable approach to preventing Vitamin K 
deficiency bleeding [15].
In our study, 68% drugs were prescribed by generic name which is 
appreciable and consistent with finding of Chatterjee et al. [16] (79.7). 
Increasing generic prescribing would rationalize the use and reduce the 
cost of drugs.
Higher incidences (98%) of antibiotic exposure in NICU could be due 
to the common practice of instituting emperical therapy and can be 
attributed to higher incidence of infections due to pollution, poor 
sanitation, and lower rate of literacy. However, inappropriate use of 
antibiotics leads to emergence of resistance.
Neonates are more vulnerable group due to immaturity of their body 
functions, and great care needs to be taken to use the minimum number 
of drugs. The development of effective control programs through 
adoption of measures that restrict use of specific antimicrobials, 
establishment of therapeutic guideline, a constant monitoring of 
the resistance pattern of the common pathogenic organisms in the 
hospital are recommended to improve the usage of antibiotics.
CONCLUSION
This study gave us an overall pattern of drug use profile in a tertiary 
care NICU and reflects the problems for which neonates were admitted 
to the NICU. The largest number of drugs per day were given in the 
1st week in NICU. Antibiotics were of major concern. Similar studies 
done on a larger scale and at regular intervals can reflect the changing 
pattern of drug prescribing which helps authority in planning to make 
necessary drugs available.
Limitations
This data are from only one institute. Multicentric studies in this subject 
are needed, particularly over a period of a year, to avoid seasonal 
variation of disease pattern.
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